About Clario
Clario is a clinical trial technology company that provides comprehensive endpoint solutions and evidence generation services for pharmaceutical, biotechnology, and contract research organizations. Now part of Thermo Fisher Scientific, Clario specializes in evaluating drug efficacy, safety, and patient quality of life through digital endpoint technologies. The company's portfolio spans cardiac solutions (ECG, arrhythmia analysis, blood pressure monitoring), electronic Clinical Outcome Assessments (eCOA), medical imaging core lab services, precision motion measurement using wearable sensors, and respiratory solutions including spirometry. Clario serves clients across all trial phases from Phase I through Phase IV, supporting both site-based and hybrid/decentralized clinical trials. The company has been pioneering AI-enabled solutions in clinical trials since 2018, with over 30 AI-powered tools deployed across 600+ active trials. Clario's technology platform includes advanced data collection, quality control, and analytics capabilities designed to accelerate drug development while reducing risk. The company serves multiple therapeutic areas including cardiovascular, neuroscience, oncology, respiratory, dermatology, gastroenterology, and ophthalmology. With a focus on regulatory compliance and scientific rigor, Clario employs key opinion leaders and clinical specialists to ensure high-quality, regulatory-ready data collection and analysis.
Clinical Focus
Medical conditions and clinical areas addressed by Clario.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired by Thermo Fisher Scientific (timing not specified in scraped content), deployed over 30 AI-enabled solutions across 600+ active trials since 2018
Key Partnerships
Social & Media
Latest Updates
Biological Psychiatry Study Shows Speech-Latency Vocal Biomarker Can Strengthen Drug–Placebo Separation in Schizophrenia Trials
4mo ago
Clario leads the way in responsible artificial intelligence with ISO 42001 certification, audited by Schellman
5mo ago
Thermo Fisher Scientific to Acquire Clario, Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
8mo ago
Clario and the University of Oxford’s NeuroMetrology Lab Advance Parkinson’s Disease Research with the Opal® Wearable Sensor System
9mo ago
Clario expands oncology trial support through collaboration with Radialogica to enhance radiation therapy quality control
10mo ago
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.